At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Adaptive DBS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Japan Post Market Adaptive Deep Brain Stimulation (aDBS) Study (Early Adapter) Part II
In Brief
A clinical study evaluating Adaptive DBS and cDBS for Parkinson Disease. Completed, enrolled 25 participants across 2 sites.
Detailed Summary
The purpose of the study is to evaluate the efficacy of aDBS (preferred mode, single or dual threshold) vs standard continuous DBS (cDBS) in decreasing Total Electrical Energy Delivered (TEED). Prospective randomized, single-blind, crossover, multicenter study of aDBS in subjects with Parkinson's disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartNov 2021
Primary CompletionMay 2023
Study CompletionOct 2023
First PostedAug 2025
TodayJul 2026
First PostedAug 6, 2025
Enrollment StartNov 29, 2021
Primary CompletionMay 8, 2023
Study CompletionOct 23, 2023
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11 months ago
Interventions
Adaptive DBSdevice
Subjects will receive Dual or Single Threshold aDBS which are acceptable
cDBSdevice
cDBS